A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE
Article in Journal of Oncology (September 2022)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Article in Journal of Oncology (September 2022)
Article in Journal of Medicinal Chemistry (December 2020)
Article in Cancer Research (October 2020)